242 related articles for article (PubMed ID: 36233189)
1. Deciphering Mechanisms of Action of Sortilin/Neurotensin Receptor-3 in the Proliferation Regulation of Colorectal and Other Cancers.
Mazella J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233189
[TBL] [Abstract][Full Text] [Related]
2. Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation.
Béraud-Dufour S; Devader C; Massa F; Roulot M; Coppola T; Mazella J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834811
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration.
Kim JT; Napier DL; Weiss HL; Lee EY; Townsend CM; Evers BM
Neoplasia; 2018 Feb; 20(2):175-181. PubMed ID: 29272741
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin pathway in digestive cancers and clinical applications: an overview.
Christou N; Blondy S; David V; Verdier M; Lalloué F; Jauberteau MO; Mathonnet M; Perraud A
Cell Death Dis; 2020 Dec; 11(12):1027. PubMed ID: 33268796
[TBL] [Abstract][Full Text] [Related]
5. Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?
Mazella J
Cell Signal; 2001 Jan; 13(1):1-6. PubMed ID: 11257441
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications.
Qiu S; Nikolaou S; Zhu J; Jeffery P; Goldin R; Kinross J; Alexander JL; Rasheed S; Tekkis P; Kontovounisios C
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32764278
[No Abstract] [Full Text] [Related]
7. The multifaceted role of sortilin/neurotensin receptor 3 in human cancer development.
Ghaemimanesh F; Mehravar M; Milani S; Poursani EM; Saliminejad K
J Cell Physiol; 2021 Sep; 236(9):6271-6281. PubMed ID: 33634506
[TBL] [Abstract][Full Text] [Related]
8. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding.
Munck Petersen C; Nielsen MS; Jacobsen C; Tauris J; Jacobsen L; Gliemann J; Moestrup SK; Madsen P
EMBO J; 1999 Feb; 18(3):595-604. PubMed ID: 9927419
[TBL] [Abstract][Full Text] [Related]
9. Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain.
Richner M; Pallesen LT; Ulrichsen M; Poulsen ET; Holm TH; Login H; Castonguay A; Lorenzo LE; Gonçalves NP; Andersen OM; Lykke-Hartmann K; Enghild JJ; Rønn LCB; Malik IJ; De Koninck Y; Bjerrum OJ; Vægter CB; Nykjær A
Sci Adv; 2019 Jun; 5(6):eaav9946. PubMed ID: 31223654
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin receptor-2 and -3 are crucial for the anti-apoptotic effect of neurotensin on pancreatic beta-TC3 cells.
Béraud-Dufour S; Coppola T; Massa F; Mazella J
Int J Biochem Cell Biol; 2009 Dec; 41(12):2398-402. PubMed ID: 19891061
[TBL] [Abstract][Full Text] [Related]
11. The implications of sortilin/vps10p domain receptors in neurological and human diseases.
Wilson CM; Naves T; Saada S; Pinet S; Vincent F; Lalloué F; Jauberteau MO
CNS Neurol Disord Drug Targets; 2014; 13(8):1354-65. PubMed ID: 25345507
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of NTSR3 inhibits cell growth and metastasis, as well as the PI3K-AKT and MAPK signaling pathways in colorectal cancer.
Liu A; Zuo Z; Liu L; Liu L
Biochem Cell Biol; 2020 Oct; 98(5):548-555. PubMed ID: 32125883
[TBL] [Abstract][Full Text] [Related]
13. Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line.
Navarro V; Vincent JP; Mazella J
Biochem Biophys Res Commun; 2002 Nov; 298(5):760-4. PubMed ID: 12419319
[TBL] [Abstract][Full Text] [Related]
14. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells.
Morinville A; Martin S; Lavallée M; Vincent JP; Beaudet A; Mazella J
Int J Biochem Cell Biol; 2004 Nov; 36(11):2153-68. PubMed ID: 15313463
[TBL] [Abstract][Full Text] [Related]
15. The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1.
Mazella J; Borsotto M; Heurteaux C
Front Pharmacol; 2018; 9():1541. PubMed ID: 30670975
[TBL] [Abstract][Full Text] [Related]
16. Increased Brain Neurotensin and NTSR2 Lead to Weak Nociception in NTSR3/Sortilin Knockout Mice.
Devader C; Moreno S; Roulot M; Deval E; Dix T; Morales CR; Mazella J
Front Neurosci; 2016; 10():542. PubMed ID: 27932946
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches targeting the neurotensin receptors.
Iyer MR; Kunos G
Expert Opin Ther Pat; 2021 May; 31(5):361-386. PubMed ID: 33393392
[No Abstract] [Full Text] [Related]
18. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
[TBL] [Abstract][Full Text] [Related]
19. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Kim JT; Weiss HL; Evers BM
Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
[TBL] [Abstract][Full Text] [Related]
20. Balancing neurotrophin pathway and sortilin function: Its role in human disease.
Al-Yozbaki M; Acha-Sagredo A; George A; Liloglou T; Wilson CM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188429. PubMed ID: 32956766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
